S. For-the and A. , Steering Committee and list of collaborators and www.art-cohort-collaboration.org for the Steering Committee and a list of ART-CC collaborators. 1. World Health Organization. Towards universal access by 2010: How WHO is working with countries to scale-up HIV prevention, treatment, care and support, 2007.

L. Ivers, D. Kendrick, and K. Doucette, Efficacy of Antiretroviral Therapy Programs in Resource???Poor Settings: A Meta???analysis of the Published Literature, Clinical Infectious Diseases, vol.41, issue.2, 2005.
DOI : 10.1086/431199

P. Braitstein, M. Brinkhof, F. Dabis, M. Schechter, A. Boulle et al., Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, pp.817-841, 2006.

S. Lawn, L. Bekker, and R. Miller, Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals, The Lancet Infectious Diseases, vol.5, issue.6, pp.361-73, 2005.
DOI : 10.1016/S1473-3099(05)70140-7

F. Dabis, E. Balestre, P. Braitstein, P. Miotti, W. Brinkhof et al., Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts, Int J Epidemiol, vol.34, pp.979-86, 2005.

M. Egger, M. May, G. Chene, A. Phillips, B. Ledergerber et al., Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, The Lancet, vol.360, issue.9327, pp.119-148, 2002.
DOI : 10.1016/S0140-6736(02)09411-4

L. Connolly, P. Edelstein, and L. Ramakrishnan, Why Is Long-Term Therapy Required to Cure Tuberculosis?, PLoS Medicine, vol.332, issue.3, p.120, 2007.
DOI : 10.1371/journal.pmed.0040120.st001

E. Girardi, C. Sabin, D. Arminio, M. Hogg, B. Phillips et al., Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America, Clin Infect Dis, vol.41, pp.1772-82, 2005.

S. Lawn, L. Bekker, and R. Wood, How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control, AIDS, vol.19, issue.11, pp.1113-1137, 2005.
DOI : 10.1097/01.aids.0000176211.08581.5a

H. Tindo, C. Cavalente, S. Werneck-barroso, and E. , Gender differences in tuberculosis in Rio de Janeiro, Brasil, Int J Tuberc Lung Dis, vol.8, pp.388-90, 2004.

J. Austin, J. Dick, and M. Zwarenstein, Gender disparity amongst TB suspects and new TB patients according to data recorded at the South African Institute of Medical Research laboratory for the Western Cape Region of South Africa, Int J Tuberc Lung Dis, vol.8, pp.435-444, 2004.

M. May, J. Sterne, D. Costagliola, C. Sabin, A. Phillips et al., HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis, Lancet, vol.368, pp.451-459, 2006.

E. Corbett, B. Marston, G. Churchyard, D. Cock, and K. , Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment, The Lancet, vol.367, issue.9514, pp.926-963, 2006.
DOI : 10.1016/S0140-6736(06)68383-9